University Hospitals Stroke Conference and Neuroscience Nursing Symposium

Release Date: September 26, 2019
Expiration Date: September 25, 2022

PROGRAM AGENDA


Stroke Systems of Care

Dr. Sila reports no financial relationship with a commercial interest relevant to this activity.

Mechanical Thrombectomy

Dr. Hu reports no financial relationship with a commercial interest relevant to this activity.

Stroke Mimics

Dr. Grosso reports no financial relationship with a commercial interest relevant to this activity.

PFO and Stroke

Dr. Bocks has received consulting fees from Edwards Lifesciences, and the CME Program has determined there is no conflict of interest. Presentation includes discussion of unlabeled/investigational uses of a commercial product.

Pediatric Strokes

Dr. Wyllie reports no financial relationship with a commercial interest relevant to this activity.

Intracerebral Hemorrhage Management

Dr. Hoffer reports no financial relationship with a commercial interest relevant to this activity.

Brain Death

Dr. DeGeorgia reports no financial relationship with a commercial interest relevant to this activity.

Carotid Stenting

Dr. Ray reports no financial relationship with a commercial interest relevant to this activity.

Diabetes and Stroke

Dr. Howley reports no financial relationship with a commercial interest relevant to this activity.

Target Audience

This continuing medical education activity is intended for physicians, nurses and other allied health professionals.  

Learning Objectives

After participating in this activity participants will be able to:

  • Discuss the UH System Stroke Program triage and treatment guidelines and High Reliability Medicine Initiatives  
  • Describe Mechanical thrombectomy treatment, risks and benefits for an acute ischemic stroke patient  
  • Identify Stroke Mimics in the hyper acute care of a potential stroke patient in the Emergency Department
  • Describe relationship between a Patent Foramen Ovale and the risk of Stroke and treatment options
  • Identify Pediatric Stroke Etiologies and describe the appropriate workup 
  • Discuss and illustrate the surgical treatment options and anticoagulation reversal for Intracerebral Hemorrhage patient  
  • Identify Brain Death criteria
  • Describe carotid stenting treatment options for patient with carotid disease 
  • Discuss strategies how to educate patient and family members about Diabetes mellitus 

Media

Recorded slides and audio presentation. Power point slides with videos.

Planning Committee

Cathy Sila MD, FAHA

Melissa Brately BSN, RN, CNRN  

Kim Findura BSN, RN

Julie Fussner BSN, RN, CPHQ, SCRN

Kelly Montgomery BSN, RN, SCRN

Danielle Sindelar MSN, RN, CMSRN

Natalie Smith BSN, CMSRN, SCRN

Erin Supan MSN, RN, APRN-CNS, CNRN  

Chase Vlad BSN, RN, CCRN

No Planning Committee member indicated a financial interest relevant to this activity.

Continuing Education

Case Western Reserve University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Case Western Reserve University School of Medicine designates this enduring material for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center, and the National Commission on Certification of Physician Assistants (NCCPA), accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

Disclosure Statement

The policy of Case Western Reserve University School of Medicine CME Program (CWRU CME) requires that the Activity Director, planning committee members and all activity faculty (that is, anyone in a position to control the content of the educational activity) disclose to the activity participants all relevant financial relationships with commercial interests. Where disclosures have been made, conflicts of interest, real or apparent, must be resolved. Disclosure will be made to activity participants prior to the commencement of the activity. CWRU CME also requires that faculty make clinical recommendations based on the best available scientific evidence and that faculty identify any discussion of “off-label” or investigational use of pharmaceutical products or medical devices.

Acknowledgments

This activity was supported by grants from Abbott, Cerenovus and Stryker Corporation.

 

Instructions

To receive statements of credit for up to 6.5 AMA PRA Category 1 CreditsTM you must:

  1. Review and reflect on the full content of the recorded session.
  2. Successfully complete the post-test. A score of 75% is required for passage.
  3. Complete the evaluation and claim your credit.

Your credits will be recorded by the CWRU CME Program and made a part of your cumulative transcript.

Estimated Time to Complete this Educational Activity

Including review of any resource material and completion of the post-test, this activity is expected to take 6.5 hours to complete all modules.

Fee

There is no fee for this program.

To contact the CME Provider: Email CWRU CME at medcme@case.edu

Resources

  1. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke
  2. A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Reviewed for evidence-based integrity and endorsed by the American Association of Neurological Surgeons and Congress of Neurological Surgeons Endorsed by the Society for Academic Emergency Medicine. William J. Powers, MD, FAHA, Chair; and et al Stroke. 2018;49:eXXX–eXXX. doi: 10.1161/STR.0000000000000158.
  3. Predictors of acute stroke mimics in 8187 patients referred to a stroke service. Merino, J. G., and et al. Journal of Stroke and Cerebrovascular Diseases, (2013) 22(8).
  4. Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials Ahmad et al. European Heart Journal, (2018) 39, 1638–1649
  5. Risk factors for pediatric stroke: consequences for therapy and quality of life. Simma B, Martin G, Müller T, Huemer M.  Pediatric Neurol. 2007;37:121–126.
  6. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association J. Claude Hemphill III, MD, MAS, FAHA, Chair; and et al on behalf of the American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology Stroke. 2015; 46:2032-2060 published online May 28, 2015 
  7. Evidence-based Guideline Update: Determining brain death in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology, Wijdicks EFM, Neurology. 2010;54:1911-1918
  8. Stenting versus endarterectomy for treatment of carotid-artery stenosis. Brott TG and et al. N Engl J Med. 2010 Jul 1;363(1):11-
  9. American Association of Diabetes Educators. (2017). The art and science of diabetes self-management education desk reference (4th edition). Chicago, IL: American Association of Diabetes Educators.